Scientists have developed a tool that can predict how bowel cancer adapts to treatment—helping researchers to design new ...

Durvalumab (Imfinzi) is a PD-L1–blocking antibody that has 3 indications for non–small cell lung cancer (NSCLC). February ...

New research shows that treatment timing is key when it comes to deciding between immunotherapy and chemoimmunotherapy for ...

Actor Dipika Kakar revealed she abruptly stopped breastfeeding her son after being diagnosed with stage 2 liver cancer. The decision was emotional but necessary due to treatment risks and safety ...

Justin Taylor, M.D., a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller ...

Median overall survival was 5 months longer in patients with small cell lung cancer (SCLC) who received tarlatamab instead of ...

The venom of a common species of Amazonian scorpion may give rise to a potential drug for treating a cancer that is one of ...

A chemotherapy-free approach for some patients suffering from leukaemia could lead to better outcomes, scientists behind a ...

Veteran actor Aruna Irani has finally revealed how she fought breast cancer twice and admitted that ignoring her doctor’s ...

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve ...

Revolutionary advancements in blood cancer treatment, from targeted therapy to gene editing, promise more effective and ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.